Evaluation of a new protocol for controlling blood glucose in hospitalized patients

Phase 3

• Conditions: Condition 1: Diabetes. Condition 2: Pneumonia. Condition 3: cellulitis. Condition 4: Diabetic foot infection.; Diabetes mellitus due to underlying condition; Streptococcus pneumoniae as the cause of diseases classified elsewhere; Cellulitis of toe; Personal history of diabetic foot ulcer; B95.3; L03.03; Z86.31

• Registration Number: IRCT20130917014693N9
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 108

Inclusion Criteria

Patients with diabetes mellitus
Age more than 18 years ago
Patients under subcutaneous insulin regimen
Patients who hospitalized in infectious diseases ward due to pneumonia, cellulitis, and diabetic foot infection

Exclusion Criteria

Pregnant women
Surgical patients
Patients on intravenous insulin
Patients with end stage renal disease
Patients on total parental nutrition
Patients who did not sign the patient informed consent form

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood glucose level. Timepoint: Every six hours. Method of measurement: Glucometer.

Secondary Outcome Measures

Name	Time	Method
Fever. Timepoint: Every six hours. Method of measurement: Mercury Therommeter.;Durration of hospitalization. Timepoint: At discharged. Method of measurement: Patient record.